XML 175 R17.htm IDEA: XBRL DOCUMENT v3.20.1
Non-controlling interests
12 Months Ended
Dec. 31, 2019
Disclosure of subsidiaries [abstract]  
Non-controlling interests
11. Non-controlling interests
The following table summarizes the information relating to each of the Company’s subsidiaries that has material non-controlling interests (“NCI”). The amounts disclosed for each subsidiary are based on those included in the consolidated financial statements before inter-company eliminations.
December 31, 2019
Hellas

 
Deva

NCI percentage
5
%
 
19.5
%
 
 
 
 
Current assets
$
67,902

 
$
1,867

Non-current assets
1,858,544

 
415,149

Current liabilities
(1,050,952
)
 
(312
)
Non-current liabilities
(405,318
)
 
(294,493
)
Net assets
$
470,176

 
$
122,211

 
 
 
 
Carrying amount of NCI
$
13,362

 
$
42,903

 
 
 
 
Cash flows (used in) generated from operating activities
$
(215
)
 
$
(4,856
)
Cash flows used in investing activities
(45,216
)
 
(15
)
Cash flows generated from (used in) financing activities
50,026

 
4,803

Net increase (decrease) in cash and cash equivalents
$
4,595

 
$
(68
)
 
 
 
 
Revenue
$
140,156

 
$

Net loss and comprehensive loss
(107,758
)
 
(6,494
)
Net loss allocated to NCI
(5,388
)
 
(1,266
)
Dividends paid to NCI

 

 
 
 
 
December 31, 2018
Hellas

 
Deva

NCI percentage
5
%
 
19.5
%
 
 
 
 
Current assets
$
78,308

 
$
2,177

Non-current assets
1,846,952

 
414,330

Current liabilities
(191,936
)
 
(536
)
Non-current liabilities
(1,181,693
)
 
(289,134
)
Net assets
$
551,631

 
$
126,837

 
 
 
 
Carrying amount of NCI
$
17,619

 
$
44,169

 
 
 
 
Cash flows used in operating activities
$
(66,135
)
 
$
(16,695
)
Cash flows used in investing activities
(80,306
)
 
(419
)
Cash flows generated from financing activities
133,520

 
15,218

Net increase (decrease) in cash and cash equivalents
$
(12,921
)
 
$
(1,896
)
 
 
 
 
Revenue
$
110,488

 
$

Net loss and comprehensive loss
(298,272
)
 
(14,100
)
Net loss allocated to NCI
(14,913
)
 
(2,750
)
Dividends paid to NCI

 



Net loss allocated to NCI in the consolidated statement of operations includes $247 related to non-material subsidiaries (2018$84). The carrying value of the NCI related to non-material subsidiaries is $3,039 (2018$1,626).